Using the 4 Pillars to Increase Vaccination Among High-Risk Adults: Who Benefits?

被引:0
|
作者
Nowalk, Mary Patricia [1 ]
Moehling, Krissy K. [1 ]
Zhang, Song [1 ]
Raviotta, Jonathan M. [1 ]
Zimmerman, Richard K. [1 ]
Lin, Chyongchiou J. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Family Med, Pittsburgh, PA 15260 USA
基金
美国国家卫生研究院;
关键词
PRACTICE TRANSFORMATION PROGRAM; UNITED-STATES; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; PNEUMOCOCCAL POLYSACCHARIDE; INFLUENZA VACCINATION; IMPROVE INFLUENZA; COVERAGE; RECOMMENDATIONS; INTERVENTIONS;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVES: To compare changes in vaccination rates (pneumococcal polysaccharide vaccine [PPSV]; tetanus, diphtheria, and pertussis [Tdap] vaccine; and influenza vaccine) among high-risk adults following an intervention (June 1, 2013, to January 31, 2015) that used the 4 Pillars Practice Transformation Program (4 Pillars Program). STUDY DESIGN: Post hoc analysis of data from a randomized controlled cluster trial. METHODS: Eighteen primary care practices received staff education, guidance for using the 4 Pillars Program, and support for a practice immunization champion. Paired t tests were used to compare vaccination rates separately for those with diabetes, chronic lung or chronic heart disease, or other high-risk conditions. Student's t tests were used to compare vaccination rates across high-risk conditions. Generalized estimating equation modeling was used to determine the likelihood of vaccination. RESULTS: Based on International Classification of Diseases, Ninth Revision, Clinical Modification codes, 4737 patients aged 18 to 64 years were identified as having diabetes (n = 1999), chronic heart disease (n = 658), chronic lung disease (n = 1682), or another high-risk condition (n = 764). PPSV uptake increased by 12.2 percentage points (PP), Tdap vaccination increased by 11.4 PP, and influenza vaccination increased by 4.8 PP. In regression analyses, patients with diabetes (odds ratio [OR], 2.2; 95% CI, 1.80-2.73), chronic lung disease (OR, 1.50; 95% CI, 1.21-1.87), or chronic heart disease (OR, 1.32; 95% CI, 1.02-1.71) were more likely to receive PPSV than those without the respective high-risk condition. Those with diabetes (OR, 1.14; 95% CI, 1.01-1.28) or chronic lung disease (OR, 1.14; 95% CI, 1.01-1.30) were more likely to receive an influenza vaccine than those without the respective condition. The likelihood of Tdap vaccination was not significantly associated with any of the chronic conditions tested. CONCLUSIONS: An intervention including the 4 Pillars Program was associated with significant increases in vaccination of high-risk adults. However, the overall uptake of recommended vaccines for those with high-risk conditions remained below national goals.
引用
收藏
页码:651 / +
页数:6
相关论文
共 50 条
  • [31] Delivering Influenza Vaccine to High-Risk Adults: Subspecialty Physician Practices
    Jessop, Amy B.
    Dumas, Harry
    Moser, Charlotte A.
    AMERICAN JOURNAL OF MEDICAL QUALITY, 2013, 28 (03) : 232 - 237
  • [32] Overcoming the barriers to HPV vaccination in high-risk populations in the US
    Downs, Levi S., Jr.
    Scarinci, Isabel
    Einstein, Mark H.
    Collins, Yvonne
    Flowers, Lisa
    GYNECOLOGIC ONCOLOGY, 2010, 117 (03) : 486 - 490
  • [33] Impact of national influenza vaccination strategy in severe influenza outcomes among the high-risk Portuguese population
    Machado, Ausenda
    Kislaya, Irina
    Larrauri, Amparo
    Dias, Carlos Matias
    Nunes, Baltazar
    BMC PUBLIC HEALTH, 2019, 19 (01)
  • [34] Influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination among adults 25 to 64 years of age with high-risk conditions-United States, 2010
    Lu, Peng-jun
    Gonzalez-Feliciano, Amparo
    Ding, Helen
    Bryan, Leah N.
    Yankey, David
    Monsell, Elizabeth A.
    Greby, Stacie M.
    Euler, Gary L.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2013, 41 (08) : 702 - 709
  • [35] Characterizing competence among a high-risk sample of emerging adults: Prospective predictions and biological considerations
    Russotti, Justin
    Warmingham, Jennifer M.
    Handley, Elizabeth D.
    Rogosch, Fred A.
    Cicchetti, Dante
    DEVELOPMENT AND PSYCHOPATHOLOGY, 2020, 32 (05) : 1937 - 1953
  • [36] Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?
    Papadatou, Ioanna
    Spoulou, Vana
    CLINICAL AND VACCINE IMMUNOLOGY, 2016, 23 (05) : 388 - 395
  • [37] Cost-effectiveness of increasing vaccination in high-risk adults aged 18-64 Years: a model-based decision analysis
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Zimmerman, Richard K.
    Smith, Kenneth J.
    Lin, Chyongchiou J.
    BMC INFECTIOUS DISEASES, 2018, 18
  • [38] Who knew? Awareness of being recommended for influenza vaccination among US adults
    Maurer, Juergen
    Harris, Katherine M.
    Parker, Andrew M.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2012, 6 (04) : 284 - 290
  • [39] Breast for Success: A Community-Academic Collaboration to Increase Breastfeeding Among High-Risk Mothers in Cleveland
    Furman, Lydia
    Matthews, Lisa
    Davis, Valeria
    Killpack, Steve
    O'Riordan, Mary Ann
    PROGRESS IN COMMUNITY HEALTH PARTNERSHIPS-RESEARCH EDUCATION AND ACTION, 2016, 10 (03) : 341 - 353
  • [40] Missed opportunities for pneumococcal vaccinations in high-risk and older adults in the United States
    Olasupo, Omotola
    Segal, Richard
    Brown, Joshua
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (01) : 101 - 103